CRISPR Therapeutics reached a significant milestone a couple of years ago: its first product approval. The company’s stock, ...
The first infant to undergo gene-editing therapy has accomplished another first — his first steps. KJ Muldoon is walking and ...
The baby saved from a rare disease by a first-ever personalized gene fix has reached a big milestone, taking his first steps ...
Morning Overview on MSN
CRISPR boosts a little-known fruit into a big farming win
Goldenberries have long been a niche curiosity, tucked into specialty produce aisles and health food shops while tomatoes and ...
A miracle baby who was treated with a pioneering gene-therapy at CHOP has reached a major milestone as he took his first ...
The company does possess a lot of potential, with its approved gene-editing treatment Casgevy. Unfortunately, sales from that ...
CRISPR is a gene-editing tool that acts like “molecular scissors,” but using it on cancer is complex. The technology’s biggest impact so far is in research labs, helping scientists understand how ...
Study finds CRISPR/Cas gene editing causes “chromatin fatigue” – another surprise mechanism by which it can produce unwanted ...
Karthik and her team aimed to use CRISPR as a way to identify and isolate a protein generated by the bacteria that cause Lyme ...
Gene editing has rapidly evolved into a transformative class of technologies that allow scientists to precisely insert, ...
From rare diseases to chronic conditions, epigenetic editing unlocks new ways to control gene activity without altering the genetic code.
Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made notable portfolio adjustments ahead of Christmas, on December 23, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback